Security key
60855D309
Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (MBRX)
CUSIP: 60855D309
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $.001 per share
- Total 13F shares
- 258,464
- Total 13F value
- $1,528,467
- Share change
- +258,464
- SEC-reported price per share
- $5.91
- Number of holders
- 18
- Value change
- +$1,528,467
- Number of buys
- 18
- Shares outstanding
- 31,794,008
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
18
Top holders
10
MBRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Moleculin Biotech, Inc. SEC filings
Moleculin Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 60855D309
Recent filing periods:
Ownership snapshot
Top reported holders of MBRX - Moleculin Biotech, Inc. - Common Stock, par value $.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
Highest disclosed value: $2,753,247
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $2.75M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$2.75M
VANGUARD GROUP INC
$927.2K
GEODE CAPITAL MANAGEMENT, LLC
$211.8K
BlackRock Finance, Inc.
$162.2K
RENAISSANCE TECHNOLOGIES LLC
$111K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
class O/S missing
|
$2,753,247
3,207,417 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$927,177
1,080,122 shares
|
— | 31 Dec 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$211,802
246,670 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$162,172
188,924 shares
|
— | 31 Dec 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
class O/S missing
|
$111,000
129,600 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
—
class O/S missing
|
$61,287
71,397 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
258,464
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q3 2025 Across Filers
Q3 2025 holders
24
Q1 2024 holders
18
Holder diff
-6
| Investor | Q3 2025 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend